Perspective Therapeutics, Inc. — Director's Dealing 2019

Sep 20, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Isoray, Inc. (ISR)
CIK: 0000728387
Period of Report: 2019-05-30

Reporting Person: Cline Krista (Dir. of Operations, Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-30	Common Stock	M	21900	$0.26	Acquired	22933	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-30	Stock Options (right to buy)	$0.26	M	21900	Disposed	2019-06-01	Common Stock (21900)	Direct

Footnotes

F1: 21,900 stock options were granted on 6/1/2009. The shares were vested 6/1/2013.